Cryptos: 31,598 Exchanges: 354 Market Cap: $2,466.35B 24h Vol: $69.74B Dominance: BTC 55.4% ETH 12.2% ETH Gas:  4 Gwei
Seclect Currency

Fiat currencies

    Crypto Currencies

      No results for ""

      We couldn't find anything matching your search.Try again with a different term.

      SuperSight's Logo

      SuperSight - Pre-seed

      Overview Investors Founders Company Profile / Project Introduction

      Overview

      Funding Date

      July 5, 2023

      Financing amount

      $1M

      Valuation

      --

      Catagory

      Others

      Subcategory

      AI

      About SuperSight - Pre-seed

      SuperSight, a London-based Generative AI startup, is redefining the crypto data landscape with its revolutionary Large Language Models (LLMs) tailored for crypto data. The company is thrilled to announce a $1M pre-seed round, backed by Blockchain Founders Fund, Animoca Brands, Druid Ventures, Emurgo, Next Gen Web 3, VaynerFund, and others. This milestone paves the way for SuperSight to accelerate their development of vertical-specific foundational models.

      Investors

      InvestorsTypeLocationYear Founded#Portfolio CompaniesEmail AddressSocials
      Fund Singapore 2018 46 investment@blockchainff.com
      Corporate Hong Kong 2014 313 --
      Fund Unknown -- 8 --
      Corporate Singapore 2017 30 --
      Fund Unknown -- 1 contact@nextgen-web3.com
      Fund United States of America 2014 19 --

      Founders & Team

      Sungjung Kim's Logo

      Sungjung Kim

      Advait Jayant's Logo

      Advait Jayant

      Mohammed Junaid's Logo

      Mohammed Junaid

      Company Profile / Project Introduction

      SuperSight (UK) is building crypto-specific Large Language Models (LLMs) to streamline the crypto data discovery process. In a sea of 420 million crypto wallets, only 30,000 users can keep up with the narratives programmatically. SuperSight bridges this gap, providing one-click search across both on-chain and off-chain sources.

      View More
      *Fundraising Announcement: Click here